N Scott Fine
CIK 1163556 · Chief Executive Officer · last filed 2024-06-05
N Scott Fine is a Chief Executive Officer who has filed 42 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for CYTHW, was dated Jun 5, 2024. Across all open-market trades the lifetime net is +$149.9K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CYTHW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10016
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Chief Executive Officer | 743,804 | $0.03 | $23.8K | $371.1K | 14 | 2024-06-05 |
| Forward Industries, Inc. (FORD) Delisted | Director | 10,500 | $9.48 | $99.5K | $0 | 3 | 2017-06-13 |
| CENTRAL EUROPEAN DISTRIBUTION CORP (CEDC) Delisted | Director | 3,707 | — | — | -$221.3K | 8 | 2011-05-23 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-05 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-23 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Mixed | +299,402 | $212.6K | EDGAR |
| 2023-04-24 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +299,402 | $212.6K | EDGAR |
| 2023-03-09 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-07 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +10,334 | $37.0K | EDGAR |
| 2022-01-19 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +5,000 | $19.4K | EDGAR |
| 2021-12-15 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +5,000 | $19.4K | EDGAR |
| 2021-12-02 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +5,000 | $24.6K | EDGAR |
| 2021-11-19 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +5,000 | $26.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.